糖尿病肾病及其危险因素的研究进展
Advances in the Study of Diabetic Kidney Disease and Its Risk Factors
DOI: 10.12677/ACM.2022.12101314, PDF,   
作者: 时天鹭, 刘云霞:西安医学院研究生处,陕西 西安;西安市第九医院内分泌科,陕西 西安;牛 瑜, 王述进*:西安市第九医院内分泌科,陕西 西安
关键词: 糖尿病肾病危险因素Diabetic Kidney Disease (DKD) Risk Factors
摘要: 糖尿病肾病(DKD)是糖尿病最常见的微血管并发症之一,其已经成为需要肾脏替代治疗的终末期肾脏病的首要原因,严重影响患者的生活质量并增加社会医疗负担。多种危险因素可通过不同机制参与DKD的发生和发展,如血糖、血压、血脂、尿酸可增加氧化应激、激活肾素血管紧张素醛固酮系统、损害肾小球滤过屏障,内脏脂肪增多引起异位脂肪沉积、加重胰岛素抵抗,吸烟增加促纤维化细胞因子的表达,贫血引起组织缺氧加重肾纤维化等。这些危险因素大多可以通过积极治疗及改变生活方式得到改善。因此,早期识别DKD的危险因素并综合管理对降低其发病率和死亡率起决定性作用。这篇综述总结了DKD的定义、分期、危险因素及对可改变危险因素的管理,可为临床提供指导。
Abstract: Diabetic kidney disease (DKD) is one of the most common microvascular complications of diabetes mellitus, and it has become the leading cause of end-stage renal disease requiring renal replace-ment therapy, which seriously affects the quality of life of patients and increases the medical bur-den of the society. Multiple risk factors can be involved in the development and progression of DKD through various mechanisms, such as blood glucose, blood pressure, lipids, and uric acid can in-crease oxidative stress, activate the renin angiotensin aldosterone system, damage the glomerular filtration barrier, increased visceral fat causes ectopic fat deposition, aggravate insulin resistance; smoking increases the expression of profibrotic cytokines, anemia causes tissue hypoxia aggravates renal fibrosis, etc. Most of these risk factors can be improved by active treatment and lifestyle changes. Therefore, the early identification of risk factors for DKD and their integrated management can play a decisive role in reducing its morbidity and mortality. This review summarizes the defini-tion, staging, risk factors and management of modifiable risk factors for DKD to provide clinical guidance.
文章引用:时天鹭, 牛瑜, 刘云霞, 王述进. 糖尿病肾病及其危险因素的研究进展[J]. 临床医学进展, 2022, 12(10): 9086-9094. https://doi.org/10.12677/ACM.2022.12101314

参考文献

[1] Saeedi, P., Petersohn, I., Salpea, P., et al. (2019) Global and Regional Diabetes Prevalence Estimates for 2019 and Pro-jections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th Edition. Diabetes Re-search and Clinical Practice, 157, Article ID: 107843. [Google Scholar] [CrossRef] [PubMed]
[2] 中华医学会肾脏病学分会专家组. 糖尿病肾脏疾病临床诊疗中国指南[J]. 中华肾脏病杂志, 2021, 37(3): 255-304.
[3] De Boer, I.H., Caramori, M.L., Chan, J.C.N., et al. (2020) KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney International, 98, S1-S115. [Google Scholar] [CrossRef] [PubMed]
[4] Gonzalez-Perez, A., Saez, M., Vizcaya, D., et al. (2021) Incidence and Risk Factors for Mortality and End-Stage Renal Disease in People with Type 2 Diabetes and Diabetic Kidney Dis-ease: A Population-Based Cohort Study in the UK. BMJ Open Diabetes Research and Care, 9, e002146. [Google Scholar] [CrossRef] [PubMed]
[5] 国家老年医学中心, 中华医学会老年医学分会, 中国老年保健协会糖尿病专业委员会. 中国老年糖尿病诊疗指南(2021年版) [J]. 中华糖尿病杂志, 2021, 13(1): 14-46.
[6] Russo, G.T., De Cosmo, S., Viazzi, F., et al. (2018) Diabetic Kidney Disease in the Elderly: Prevalence and Clinical Correlates. BMC Geriatrics, 18, Article No. 38. [Google Scholar] [CrossRef] [PubMed]
[7] Roy, S., Schweiker-Kahn, O., Jafry, B., et al. (2021) Risk Factors and Comorbidities Associated with Diabetic Kidney Disease. Journal of Primary Care & Community Health, 12, Article ID: 21501327211048556. [Google Scholar] [CrossRef] [PubMed]
[8] Jiang, W., Wang, J., Shen, X., et al. (2020) Establishment and Validation of a Risk Prediction Model for Early Diabetic Kidney Disease Based on a Systematic Review and Me-ta-Analysis of 20 Cohorts. Diabetes Care, 43, 925-933. [Google Scholar] [CrossRef] [PubMed]
[9] Farah, R.I., Al-Sabbagh, M.Q., Momani, M.S., et al. (2021) Diabetic Kid-ney Disease in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study. BMC Nephrology, 22, Article No. 223. [Google Scholar] [CrossRef] [PubMed]
[10] Wang, J., Han, Q., Zhao, L., et al. (2019) Identification of Clini-cal Predictors of Diabetic Nephropathy and Non-Diabetic Renal Disease in Chinese Patients with Type 2 Diabetes, with Reference to Disease Course and Outcome. Acta Diabetologica, 56, 939-946. [Google Scholar] [CrossRef] [PubMed]
[11] Adler, A.I., Stevens, R.J., Manley, S.E., et al. (2003) Develop-ment and Progression of Nephropathy in Type 2 Diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney International, 63, 225-232. [Google Scholar] [CrossRef] [PubMed]
[12] De Boer, I.H., Afkarian, M., Rue, T.C., et al. (2014) Renal Outcomes in Patients with Type 1 Diabetes and Macroalbuminuria. Journal of the American Society of Nephrology, 25, 2342-2350. [Google Scholar] [CrossRef
[13] Yu, M.K., Lyles, C.R., Bent-Shaw, L.A., et al. (2012) Risk Factor, Age and Sex Differences in Chronic Kidney Disease Prevalence in a Diabetic Cohort: The Pathways Study. American Journal of Nephrology, 36, 245-251. [Google Scholar] [CrossRef] [PubMed]
[14] Valdivielso, J.M., Jacobs-Cacha, C. and Soler, M.J. (2019) Sex Hormones and Their Influence on Chronic Kidney Disease. Current Opinion in Nephrology and Hypertension, 28, 1-9. [Google Scholar] [CrossRef
[15] Giandalia, A., Giuffrida, A.E., Gembillo, G., et al. (2021) Gender Differences in Diabetic Kidney Disease: Focus on Hormonal, Genetic and Clinical Factors. International Journal of Molecular Sciences, 22, Article No. 5808. [Google Scholar] [CrossRef] [PubMed]
[16] Inada, A., Inada, O., Fujii, N.L., et al. (2016) Adjusting the 17β-Estradiol-to-Androgen Ratio Ameliorates Diabetic Nephropathy. Journal of the American Society of Nephrology, 27, 3035-3050. [Google Scholar] [CrossRef
[17] Ibrahim, M.M. (2010) Subcutaneous and Visceral Adipose Tissue: Structural and Functional Differences. Obesity Reviews, 11, 11-18. [Google Scholar] [CrossRef
[18] 华艳龙, 张林. 内脏脂肪面积在糖尿病肾病危险因素筛查中的应用价值[J]. 中国基层医药, 2020, 27(5): 605-607.
[19] Khanam, P.A., Hoque, S., Begum, T., et al. (2017) Microvascular Complications and Their Associated Risk Factors in Type 2 Diabetes Mellitus. Diabetes Diabetes & Met-abolic Syndrome, 11, S577-S581. [Google Scholar] [CrossRef] [PubMed]
[20] Wang, Y., Zhao, L., Zhang, J., et al. (2019) Implications of a Family History of Diabetes and Rapid EGFR Decline in Patients with Type 2 Diabetes and Biopsy-Proven Diabetic Kidney Dis-ease. Frontiers in Endocrinology, 10, Article No. 855. [Google Scholar] [CrossRef] [PubMed]
[21] Wang, Y., Zhang, J., Zhao, Y., et al. (2018) COL4A3 Gene Variants and Diabetic Kidney Disease in Mody. Clinical Journal of the American Society of Nephrology, 13, 1162-1171. [Google Scholar] [CrossRef
[22] Doke, T., Huang, S., Qiu, C., et al. (2021) Transcriptome-Wide Association Analysis Identifies DACH1 as a Kidney Disease Risk Gene That Contributes to Fibrosis. Journal of Clinical Investigation, 131, e141801. [Google Scholar] [CrossRef
[23] Zhang, L., He, S., Guo, S., et al. (2014) Down-Regulation of Mir-34a Al-leviates Mesangial Proliferation in Vitro and Glomerular Hypertrophy in Early Diabetic Nephropathy Mice by Targeting Gas1. Journal of Diabetes and Its Complications, 28, 259-264. [Google Scholar] [CrossRef] [PubMed]
[24] 梁田田, 王惠珍, 柒春芳, 等. 糖尿病和糖尿病肾病小鼠肾组织中长链非编码RNA的差异表达[J]. 中华肾脏病杂志, 2019, 35(2): 127-135.
[25] Tommerdahl, K.L., Shapiro, A.L.B., Nehus, E.J., et al. (2022) Early Microvascular Complications in Type 1 and Type 2 Diabetes: Recent Developments and Updates. Pediatric Nephrology, 37, 79-93. [Google Scholar] [CrossRef] [PubMed]
[26] Deng, L., Aibibula, W., Talat, Z., et al. (2021) The Association between Glycaemic Control during Hospitalization and Risk of Adverse Events: A Retrospective Cohort Study. Endo-crinology, Diabetes & Metabolism, 4, e00268. [Google Scholar] [CrossRef] [PubMed]
[27] Stratton, I.M., Cull, C.A., Adler, A.I., et al. (2006) Additive Effects of Gly-caemia and Blood Pressure Exposure on Risk of Complications in Type 2 Diabetes: A Prospective Observational Study (UKPDS 75). Diabetologia, 49, 1761-1769. [Google Scholar] [CrossRef] [PubMed]
[28] Fullerton, B., Jeitler, K., Seitz, M., et al. (2014) Intensive Glucose Control versus Conventional Glucose Control for Type 1 Diabetes Mellitus. Cochrane Database of Systematic Reviews, No. 2, Article No: CD009122. [Google Scholar] [CrossRef
[29] Shurraw, S., Hemmelgarn, B., Lin, M., et al. (2011) As-sociation between Glycemic Control and Adverse Outcomes in People with Diabetes Mellitus and Chronic Kidney Dis-ease: A Population-Based Cohort Study. Archives of Internal Medicine, 171, 1920-1927. [Google Scholar] [CrossRef] [PubMed]
[30] Patel, D.M., Bose, M. and Cooper, M.E. (2020) Glucose and Blood Pressure-Dependent Pathways—The Progression of Diabetic Kidney Disease. International Journal of Molecular Sciences, 21, 2218. [Google Scholar] [CrossRef] [PubMed]
[31] 陈雪, 周倩倩, 徐慧君, 等. 不同血压变量及其变异性对2型糖尿病肾病的影响[J]. 中华内分泌代谢杂志, 2021, 37(7): 624-630.
[32] Beddhu, S., Greene, T., Boucher, R., et al. (2018) Intensive Systolic Blood Pressure Control and Incident Chronic Kidney Disease in People with and without Diabetes Mellitus: Secondary Analyses of Two Randomised Controlled Trials. The Lancet Diabetes & En-docrinology, 6, 555-563. [Google Scholar] [CrossRef
[33] De Cosmo, S., Viazzi, F., Piscitelli, P., et al. (2016) Blood Pressure Status and the Incidence of Diabetic Kidney Disease in Patients with Hypertension and Type 2 Diabetes. Journal of Hypertension, 34, 2090-2098. [Google Scholar] [CrossRef
[34] Xu, J., Xue, Y., Chen, Q., et al. (2022) Identifying Distinct Risk Thresholds of Glycated Hemoglobin and Systolic Blood Pressure for Rapid Albuminuria Progression in Type 2 Diabetes from Nhanes (1999-2018). Frontiers in Medicine, 9, Article ID: 928825. [Google Scholar] [CrossRef] [PubMed]
[35] Russo, G., Piscitelli, P., Giandalia, A., et al. (2020) Atherogenic Dyslipidemia and Diabetic Nephropathy. Journal of Nephrology, 33, 1001-1008. [Google Scholar] [CrossRef] [PubMed]
[36] Roumeliotis, S., Georgianos, P.I., Roumeliotis, A., et al. (2021) Oxidized Ldl Modifies the Association between Proteinuria and Deterioration of Kidney Function in Proteinuric Diabetic Kidney Disease. Life, 11, Article No. 504. [Google Scholar] [CrossRef] [PubMed]
[37] Lu, C.F., Liu, W.S., Chen, Z.H., et al. (2022) Comparisons of the Rela-tionships between Multiple Lipid Indices and Diabetic Kidney Disease in Patients with Type 2 Diabetes: A Cross-Sectional Study. Frontiers in Endocrinology, 13, Article ID: 888599. [Google Scholar] [CrossRef] [PubMed]
[38] Lee, T.S., Lu, T.M., Chen, C.H., et al. (2021) Hyperuricemia In-duces Endothelial Dysfunction and Accelerates Atherosclerosis by Disturbing the Asymmetric Dimethylarg-inine/Dimethylarginine Dimethylaminotransferase 2 Pathway. Redox Biology, 46, Article ID: 102108. [Google Scholar] [CrossRef] [PubMed]
[39] Bartakova, V., Kuricova, K., Pacal, L., et al. (2016) Hyperurice-mia Contributes to the Faster Progression of Diabetic Kidney Disease in Type 2 Diabetes Mellitus. Journal of Diabetes and Its Complications, 30, 1300-1307. [Google Scholar] [CrossRef] [PubMed]
[40] Lai, Y.J., Chen, Y.Y., Ku, P.W., et al. (2021) Association between Uric Acid Level and Incidence of Albuminuria in Patients with Type 2 Diabetes Mellitus: A 4.5-Year Cohort Study. Medicine, 100, e27496. [Google Scholar] [CrossRef
[41] Bjornstad, P., Laffel, L., Lynch, J., et al. (2019) Elevated Serum Uric Acid Is Associated with Greater Risk for Hypertension and Diabetic Kidney Diseases in Obese Adolescents with Type 2 Diabetes: An Observational Analysis from the Treatment Options for Type 2 Diabetes in Adolescents and Youth (Today) Study. Diabetes Care, 42, 1120-1128. [Google Scholar] [CrossRef] [PubMed]
[42] Hayashino, Y., Okamura, S., Tsujii, S., et al. (2016) Association of Serum Uric Acid Levels with the Risk of Development Or Progression of Albuminuria among Japanese Patients with Type 2 Diabetes: A Prospective Cohort Study [Diabetes Distress and Care Registry At Tenri (Ddcrt 10)]. Acta Diabetologica, 53, 599-607. [Google Scholar] [CrossRef] [PubMed]
[43] The GBD 2015 Obesity Collaborators (2017) Health Effects of Overweight and Obesity in 195 Countries Over 25 Years. New England Journal of Medicine, 377, 13-27. [Google Scholar] [CrossRef
[44] 龙洁儿, 刘振杰, 丁美祝, 等. 肥胖与糖尿病肾病相关性研究的Meta分析[J]. 中国中西医结合肾病杂志, 2021, 22(1): 29-33.
[45] Wang, Y., Chen, F., Wang, J., et al. (2019) The Relationship between Increased Ratio of Visceral-to-Subcutaneous Fat Area and Renal Outcome in Chinese Adults with Type 2 Diabetes and Diabetic Kidney Disease. Canadian Journal of Diabetes, 43, 415-420. [Google Scholar] [CrossRef] [PubMed]
[46] Yang, J.J., Yu, D., Wen, W., et al. (2019) Tobacco Smoking and Mortality in Asia: A Pooled Meta-Analysis. JAMA Network Open, 2, e191474. [Google Scholar] [CrossRef] [PubMed]
[47] Jiang, S., Quan, D.V., Sung, J.H., et al. (2019) Cigarette Smoke Inhalation Aggravates Diabetic Kidney Injury in Rats. Toxicology Research, 8, 964-971. [Google Scholar] [CrossRef] [PubMed]
[48] Obert, D.M., Hua, P., Pilkerton, M.E., et al. (2011) Environmental To-bacco Smoke Furthers Progression of Diabetic Nephropathy. The American Journal of the Medical Sciences, 341, 126-130. [Google Scholar] [CrossRef
[49] Feodoroff, M., Harjutsalo, V., Forsblom, C., et al. (2015) Smoking and Progression of Diabetic Nephropathy in Patients with Type 1 Diabetes. Acta Diabetologica, 53, 525-533. [Google Scholar] [CrossRef] [PubMed]
[50] Öberg, M., Jaakkola, M.S., Woodward, A., et al. (2011) World-wide Burden of Disease from Exposure to Second-Hand Smoke: A Retrospective Analysis of Data from 192 Countries. The Lancet, 377, 139-146. [Google Scholar] [CrossRef
[51] Jhee, J.H., Joo, Y.S., Kee, Y.K., et al. (2019) Secondhand Smoke and CKD. Clinical Journal of the American Society of Nephrology, 14, 515-522. [Google Scholar] [CrossRef
[52] Braffett, B.H., Rice, M.M., Young, H.A., et al. (2019) Mediation of the Association of Smoking and Microvascular Complications by Glycemic Control in Type 1 Diabetes. PLOS ONE, 14, e0210367. [Google Scholar] [CrossRef] [PubMed]
[53] Ito, K., Yokota, S., Watanabe, M., et al. (2021) Anemia in Dia-betic Patients Reflects Severe Tubulointerstitial Injury and Aids in Clinically Predicting a Diagnosis of Diabetic Nephrop-athy. Internal Medicine, 60, 1349-1357. [Google Scholar] [CrossRef] [PubMed]
[54] Fujita, Y., Doi, Y., Hamano, T., et al. (2019) Low Erythro-poietin Levels Predict Faster Renal Function Decline in Diabetic Patients with Anemia: A Prospective Cohort Study. Sci-entific Reports, 9, Article No. 14871. [Google Scholar] [CrossRef] [PubMed]
[55] Eren, Z., Gunal, M.Y., Ari, E., et al. (2016) Pleiotropic and Renoprotective Effects of Erythropoietin Beta on Experimental Diabetic Nephropathy Model. Nephron, 132, 292-300. [Google Scholar] [CrossRef] [PubMed]
[56] 王晓红, 左淑丽. 血清25羟基维生素D水平与糖尿病微血管病变的关系及临床意义[J]. 中国综合临床, 2020, 36(6): 496-500.
[57] Wang, Y., Yang, S., Zhou, Q., et al. (2019) Effects of Vitamin D Supplementation on Renal Function, Inflammation and Glycemic Control in Patients with Diabetic Nephropa-thy: A Systematic Review and Meta-Analysis. Kidney and Blood Pressure Research, 44, 72-87. [Google Scholar] [CrossRef] [PubMed]